384
Participants
Start Date
September 5, 2019
Primary Completion Date
September 29, 2021
Study Completion Date
September 29, 2021
Quadrivalent Recombinant Influenza Vaccine
The first recombinant inactivated influenza vaccine (RIV) using an insect baculovirus expression system and recombinant DNA technology
Quadrivalent Inactivated Influenza Vaccine
Standard inactivated influenza vaccine (IIV) manufactured involving the use of embryonated hen eggs.
Duke University Medical Center, Durham
Cincinnati Children's Hospital Medical Center, Cincinnati
Boston Medical Center, Boston
Lead Sponsor
Collaborators (1)
Children's Hospital Medical Center, Cincinnati
OTHER
Boston Medical Center
OTHER
Centers for Disease Control and Prevention
FED
Duke University
OTHER